Tell us about your exciting accomplishments!

OVPR staff is excited about the breakthroughs in research and scholarly accomplishments on our campus. If you have been awarded a grant, submitted a paper for publication or been notified that your research is being published in a scholarly journal, please contact us at so we can share the news with the rest of the OUHSC research community.

"The ORA submission process: A review for new investigators"
New PI Training 04-20-16 Final

Other helpful information

On this page, you will also find useful Institutional Data that you may be asked to provide when submitting a proposal.   Please let us know if there is additional information or links you would like to see on our site. Simply complete our Suggestion Form.

OUHSC Research News - Monday, September 6, 2021

*Alert* Effective 9/10/2021-9/14/2021, the platform on which the SoonerTrack system runs, will receive a required update in order for email functionality to remain and continue to operate as designed. During this time, users will have no access to the site. Please plan any submissions accordingly. If you have a deadline that falls within the downtime, please have your submissions in by 9/7/21. Reach out to your SPA or his/her supervisor for specific questions regarding proposals. Once back up and running, you will find that the required update resulted in some minor changes in appearance. 

  • Color theme updated:
    • Cream removed with exception of workflow background
    • Alternate colors for rows in listing components
    • Bigger font size
    • Header titles in bold
  • Routing Form:
    • “Jump to” bar replaced with “left-hand navigator”
    • Any selection lists that used to “pop up” will now “slide in” as new windows
    • “Hide/Show Errors” is replaced with “Validate” feature
    • Exit/Save/Continue buttons float as screen scrolls (Printer version has “Back to top” button/feature.

All existing functions and workflow remain the same. Please visit for a brief review of these changes. You can direct any additional questions related to the update to the We appreciate your patience during this outage.


Grant Writing Coaching Groups Study

Are you an early stage researcher ready to write a new or revised NIH-style proposal and interested in receiving coaching support while you write? If so, we invite you to apply for participation in the University of Utah Grant Writing Coaching Research Study, funded by the NIH Common Fund (grant U01 GM132366; administered by the NIGMS). This study will compare variations of an established grant writing group coaching process to identify features that influence its effectiveness. The deadline to apply is  September 13, 2021. Acceptance into the study will be confirmed by December 21, 2021. Details are at


Oklahoma EPSCoR Research Experience for Undergraduates (REU) – Summer 2022 Research Experience for

Undergraduate Students – Proposal Due November 17, 2021.  See attached document for additional information.


Presbyterian Health Foundation (PHF) Bridge Grant Program Cycle III Request For Applications

Due Date November 10, 2021

The primary objective of the PHF Bridge Grant Program is to provide funding to enhance OUHSC faculty competitiveness for extramural funding. OUHSC Principal Investigators are eligible if they meet the following criteria: 1) have submitted an extramural application within the past 18 months that was scored but not funded, 2) are requesting over $750,000 in total direct costs and over $200,000 in total facilities and administration (F&A) costs; and 3) received a review that ranks applications and provides critiques.  This program can provide funding for up to $75,000 for one year. Guidelines and Application Form are attached for or can be found here.  If you have any questions, please email

Save the Date – ORA Noon Conference offered via Zoom

September 29, 2021 at 1:00 pm

Topic: Writing Manuscripts

Description: Communicating the results of your research is an important part of the research enterprise. This presentation will cover how to write original articles and provide tools necessary to successfully write, submit, and publish a manuscript. It will introduce the purpose of each section of a research article, describe the recommended approach, and provide information about common mistakes in writing for biomedical publications. APA’s Journal Article Reporting Standards (JARS) will also be introduced.

Please register in advance for this meeting:

After registering, you will receive a confirmation email containing information about joining the meeting.

PLEASE NOTE: Change to OUHSC new NIH Other Support pages requirements. 

OUHSC will not start implementing this policy internally until October 01, 2021 (previously July 1, 2021).  Please keep in mind, that other institutions may have already implemented this policy and you may be required to use the new format for them before the OUHSC October 01, 2021 date.

OSCTR TPIR Trainee Program

Seeking applicants for the eighth year of the research training program Translating Practice into Research (TPIR). TPIR is a program for healthcare professionals, clinical investigators, basic scientists, and community health professionals and it is funded by the NIH Oklahoma Shared Clinical and Translational Resources grant. The goal of the TPIR trainee program is to produce a group of clinicians and scientists who have the ability to translate their clinical observations and ideas for improving practice into practical and feasible research projects. Attached is a detailed description and application due September 20, 2021. Practice into Research

Harold Hamm Diabetes Center (HHDC) Research Symposium CALL FOR ABSTRACTS 

The abstract submission deadline for the HHDC 2021 Research Symposium is Friday, October 1st. Abstracts must be received by 5 p.m. HHDC 2021 Research Symposium will be held VIRTUALLY on Friday, November 12, 2021. The Symposium will consist of selected oral presentations by faculty and Symposia talks by UTPAL PAJVANI, M.D., Ph.D., Associate Professor of Medicine, Columbia University, LORI SUSSEL, Ph.D., Professor of Medicine, University of Colorado Denver – Anschutz Medical Campus and KENT THORNBURG, Ph.D., Professor of Medicine, Oregon Health & Science University. For abstract submission guidelines and to RSVP for this free event, please go to:  Please contact with any questions for this event.

OUHSC American Cancer Society - Institutional Research Grant Program - FALL 2021

Purpose: ACS-IRG grants are designed to support the development of beginning investigators who have no national peer-reviewed research grant support. The program supports junior faculty conducting cancer research pilot projects to obtain preliminary results that will enable them to compete successfully for national research grants.

Eligibility: Full time Assistant Professors within six years of their first independent faculty appointment and with no active peer- reviewed research funding from national funding agencies (e.g. NIH, DOD, NSF, ACS) may apply.

Funding: Up to $50,000 per award for one year. The SCC will fund up to four awards for the FALL 2021 cycle.

Deadline for application: September 10, 2021, 5 PM.

Please refer to the flyer (attached) for application link and guidelines.

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email or  

  • Midwest Drug Development Conference ( is going virtual this October!  Please contact 
  •  or if you are developing a therapeutic and have supporting proof of concept data portfolio.  Also expected to be in the audience are investment groups who are interested in building or investing in startup companies.   
  • Johnson & Johnson Innovation is seeking collaborations with academics in the area of cell line engineering, with a particular interest in inducible expression of exogenous transgenes integrated into the genome of human HEK293 cells to allow controlled expression from suspension cultures in a large bioreactor.  Approaches of interest include: transcription factors, ligand-activated nuclear hormone receptors, riboswitches, and ligands that modulate RNA splicing.  Out of scope: post-translational modification approaches, temperature or light-activated approaches.  Submission entails a 1-pg non-confidential summary of technology and supporting validation data (deadline 9/10).
  • A global electronics manufacturing company (requested anonymity) is looking to fund projects for the development of consumer electronic devices.  Technologies of interest include: imaging sensors, AI for creating mapping information, non-invasive blood glucose sensing, non-contact human signal monitoring sensors, wearable products, innovative robotics, etc.  Out of scope: non-validated technology.  Submission entails a 1-pg non-confidential summary of technology (deadline 9/17).


NIA Announces Guidance for Purchasing Identifiable Centers for Medicare and Medicaid Services (CMS) Data in Grant Applications Effective FY 2022 (NOT-AG-21-055)

Notice to Extend the Response Date for NOT-ES-21-009 "Request for information (RFI) on Climate Change and Health" (NOT-ES-21-012)

Reminder of Guidance on Requirement for NIH Single Institutional Review Board (IRB) Plan (NOT-OD-21-174)

Extending the Special Exception to the NIH/AHRQ/NIOSH Post-Submission Material Policy During the COVID-19 Pandemic: May 2022 Council (NOT-OD-21-179)

Clarification and Guidance for Applicants Preparing Applications for the Fall 2021 Due Dates During the COVID-19 Pandemic (NOT-OD-21-180)

Notice of Intent to Re-issue RFA-RM-21-022 Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Allowed)" (NOT-RM-21-032)

Notice of Change of Award Type and further Clarifications to PAR-21-213 "Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (NOT-AG-21-056)

Notice of Participation of the National Institute on Aging (NIA) in RFA-NS-21-013 "BRAIN Initiative: Targeted BRAIN Circuits Projects- TargetedBCP (R01 Clinical Trial Not Allowed)" (NOT-AG-21-059)

Notice of NIEHS Participation in PAR-20-100 "Genomic Community Resources (U24 Clinical Trial Not Allowed)" (NOT-ES-21-010)

Notice of Participation of NINR in PAR-21-213, Urgent Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (NOT-NR-21-007)

Notice of Intent to Publish a Funding Opportunity Announcement for NIH Health Care Systems Research Collaboratory - Pragmatic and Implementation Trials of Embedded Interventions (UG3/UH3 Clinical Trials Optional) (NOT-AT-21-015)

Notice of Intent to Publish a Funding Opportunity Announcement for Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) (NOT-AT-21-016)

Notice of Intent to Publish a Funding Opportunity Announcement for the Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Optional) (NOT-OD-21-175)

Notice of Special Interest (NOSI): Maximizing the Scientific Value of Secondary Analyses of Existing Cohorts and Datasets in Order to Address Research Gaps and Foster Additional Opportunities in Aging Research (NOT-AG-21-020)

Notice of Special Interest (NOSI): Supporting Women’s Health Research in the IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase I Program (NOT-GM-21-056) 

Notice of Special Interest (NOSI): Supporting Data Sciences in the IDeA States through the Centers of Biomedical Research Excellence (COBRE) Phase I Program (NOT-GM-21-062)

Notice of Special Interest (NOSI): Genomics Education Interactive Digital Media Resources (SBIR/STTR) (NOT-HG-21-038)

HEAL Initiative: Notice of Special Interest (NOSI) regarding the Availability of Administrative Supplements to Support Strategies to Advance the Study of Chronic Overlapping Pain Conditions (COPCs) (NOT-NS-21-068)

Notice of Special Interest to Encourage Eligible NIH BRAIN Initiative Awardees to Apply for PA-21-071 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) (NOT-NS-22-012)

Please Note:  When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen   for submission from the University.


Cancer Research Education Grants Program - Courses for Skills Development (R25 Clinical Trial Not Allowed) (PAR-21-278) Deadline September 25, 2021

Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed)
(PAR-21-279) - Deadline September 25, 2021

Implementation Science for Cancer Control in People Living with HIV in Low- and Middle-Income Countries (U01 Clinical Trial Optional) (RFA-CA-21-056) - Deadline December 15, 2021

Learning Disabilities Innovation Hubs (P20 Clinical Trial Optional) (RFA-HD-22-005) - Deadline November 30, 2021

Autism Centers of Excellence: Networks (R01 Clinical Trial Optional) (RFA-HD-22-007) – Deadline November 09, 2021

Autism Centers of Excellence: Centers (P50 Clinical Trial Optional) (RFA-HD-22-008) - Deadline November 09, 2021

Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional) (RFA-HD-22-009) - Deadline November 29, 2021

Limited Competition: Continued Development of the Gabriella Miller Kids First Pediatric Data Resource Center (U2C Clinical Trial Not Allowed) (RFA-RM-21-014) - Deadline October 20, 2021


Alzheimer’s Drug Discovery Foundation (ADDF) – Neuroimaging and CSF Biomarker Program

Letter of Intent Deadline October 1, 2021. Application Deadline November 1, 2021

ADDF – Prevention Pipeline – Letter of Intent Deadline October 1, 2021. Application Deadline November 1, 2021


Documents to download